Bluejay Diagnostics (BJDX) Cash from Operations (2020 - 2026)

Bluejay Diagnostics has disclosed Cash from Operations across 7 years of filings, most recently posting 1589200.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 1589200.0, down 34.13% year-over-year; the trailing twelve-month figure through Mar 2026 was 6457918.0 (up 3.7% YoY), and the FY2025 annual result was 6053575.0, up 22.6% from the prior year.
• Cash from Operations came in at 1589200.0 for Q1 2026 at Bluejay Diagnostics, down from 1454870.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1125066.0 in Q3 2023 to a low of 2944243.0 in Q4 2022.
• The 5-year median for Cash from Operations is 1659062.0 (2022), against an average of 1854062.35.
• Across the five-year window, Cash from Operations plunged 403.8% in 2022 and jumped 48.48% in 2025, its largest moves.
• Bluejay Diagnostics' Cash from Operations stood at 2944243.0 in 2022, then advanced by 5.66% to 2777477.0 in 2023, then surged by 47.75% to 1451345.0 in 2024, then declined by 0.24% to 1454870.0 in 2025, then fell by 9.23% to 1589200.0 in 2026.
• The last three Cash from Operations figures came in at 1589200.0 (Q1 2026), 1454870.0 (Q4 2025), and 1359793.0 (Q3 2025), per Business Quant data.